CGD diagnosis in F test
in flow cy
defect
<10% F+ cells
dihydrorhodamine 123
NADPH oxidase def.
RBC phenotype in CGD
McLeod (absence of Kell)
Duncan disease
due to EBV
inverted CD4:CD8
SH2D1A gene - SAP
Chediak-Higashi defect and gene
degranulation (large granules)
LYSY/CHS1 - lysosomal trafficking regulator
NK cell function assessed by
chromium release assay
PBC antibody
AMA
autoimmune hepa antibody
anti-smooth muscle ab
anti-liver kidney microsomal
MPO-ANCA
(p-ANCA)
PSC, UC
microscopic polyangiitis
PAN
Churg-Strauss
polyarteritis nodosa assoc
Hep B
PR3-ANCA
(c-ANCA)
Wegener (granulomatosis w/ polyangiitis)
intradermal injection
5-10 mm wheal
skin-prick method
3mm
PBC criteria
2/3
AMA more or equal to 1:40
ALP more than or equal to 1.5x upper limit >2yrs
compatible liver histology
Insulin autoantibody in type 1 DM not used for
patients treated with insulin for more than 14 days
MS diagnosis
glucose normal
WBC <10 monos/uL
protein <60 mg/dl
MBP >4 ng/ml
no autoabs
Type 1 DM antibodies and method
Islet cell cyto autoantibody - indirect immunoassay
dx of allergic disease in IgE
+1 SD
basophil activation assay
CD63